公司资料
ImmunoGen 股价、新闻与催化剂
- 股票代码:
- IMGN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for IMGN.
公司概览
业务概览
ImmunoGen was an antibody-drug conjugate company focused on oncology before being acquired by AbbVie.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ prior to acquisition, it sat in oncology biotechnology.
商业模式特征
The business was driven by ADC development, commercial execution, and the value of its tumor-targeting payload platform.
生物医药行业定位
ImmunoGen was one of the defining ADC names and now belongs to biotech M&A history.
未来催化剂
- ImmunoGen is now mainly a closeout / integration story after the AbbVie transaction, so the catalysts are any remaining corporate or settlement steps rather than a live pipeline event. The market is focused on residual value and final integration details.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。